Title:
関節痛改善剤
Document Type and Number:
Japanese Patent JP7152062
Kind Code:
B2
Abstract:
To provide a joint pain ameliorating agent that exhibits repetitive continuity of excellent knee joint pain ameliorating effect.SOLUTION: A joint pain ameliorating agent contains non-modified proteoglycan having an average molecular weight of 900,000 Da and non-modified type II collagen having an average molecular weight of 300,000 Da to 400,000 Da as active ingredients. The joint pain ameliorating agent is characterized in: containing non-modified proteoglycan and non-modified type II collagen in a mass ratio of 4.5:10 to 5.5:10; and being used orally.SELECTED DRAWING: Figure 7
Inventors:
Yoshifumi Hamaguchi
Application Number:
JP2021066214A
Publication Date:
October 12, 2022
Filing Date:
April 09, 2021
Export Citation:
Assignee:
Well Venus Co., Ltd.
International Classes:
A23L33/10; A23L33/17; A61K38/17; A61K38/39; A61P19/02
Domestic Patent References:
| JP2003155250A | ||||
| JP2015013845A | ||||
| JP2014009164A | ||||
| JP2006515765A |
Foreign References:
| WO2012099224A1 | ||||
| WO2014017570A1 | ||||
| WO2007032404A1 |
Other References:
Matrix Biology, 2015年,p.11-55,http://dx.doi.org/10.1016/j.matbio.2015.02.003
Archives of Biochemistry and Biophysics, 2011年,Vol.506,p.58-65,doi:10.1016/j.abb.2010.10.025
新薬と臨床,2016年11月,Vol.65,pp.1507-1521
BioMed Research International,2014年,Vol.2014,ArticleID406453
Inflammation Research,2010年,Vol.59,pp.369-377
Archives of Biochemistry and Biophysics, 2011年,Vol.506,p.58-65,doi:10.1016/j.abb.2010.10.025
新薬と臨床,2016年11月,Vol.65,pp.1507-1521
BioMed Research International,2014年,Vol.2014,ArticleID406453
Inflammation Research,2010年,Vol.59,pp.369-377
Attorney, Agent or Firm:
Tomoko Tsujita